Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34


Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease.

Ajmera V, Perito ER, Bass NM, Terrault NA, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat BE; NASH Clinical Research Network..

Hepatology. 2017 Jan;65(1):65-77. doi: 10.1002/hep.28776. Epub 2016 Oct 12.


The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.

Rosenfield RL, Ehrmann DA.

Endocr Rev. 2016 Oct;37(5):467-520. Epub 2016 Jul 26.


Childhood obesity and its impact on the development of adolescent PCOS.

Anderson AD, Solorzano CM, McCartney CR.

Semin Reprod Med. 2014 May;32(3):202-13. doi: 10.1055/s-0034-1371092. Epub 2014 Apr 8. Review.


Clinical review: Adolescent anovulation: maturational mechanisms and implications.

Rosenfield RL.

J Clin Endocrinol Metab. 2013 Sep;98(9):3572-83. doi: 10.1210/jc.2013-1770. Epub 2013 Aug 2. Review.


Update in polycystic ovary syndrome: new criteria of diagnosis and treatment in Japan.

Kubota T.

Reprod Med Biol. 2013 Jul;12(3):71-77. Epub 2013 Apr 16.


The effects of old, new and emerging medicines on metabolic aberrations in PCOS.

Bargiota A, Diamanti-Kandarakis E.

Ther Adv Endocrinol Metab. 2012 Feb;3(1):27-47. doi: 10.1177/2042018812437355.


PAI-1 and diabetes: a journey from the bench to the bedside.

Schneider DJ, Sobel BE.

Diabetes Care. 2012 Oct;35(10):1961-7. No abstract available.


Saturated fatty acid exposure induces androgen overproduction in bovine adrenal cells.

Bellanger S, Battista MC, Fink GD, Baillargeon JP.

Steroids. 2012 Mar 10;77(4):347-53. doi: 10.1016/j.steroids.2011.12.017. Epub 2012 Jan 9.


Should all women with PCOS be treated for insulin resistance?

Marshall JC, Dunaif A.

Fertil Steril. 2012 Jan;97(1):18-22. doi: 10.1016/j.fertnstert.2011.11.036.


Determination of the source of androgen excess in functionally atypical polycystic ovary syndrome by a short dexamethasone androgen-suppression test and a low-dose ACTH test.

Rosenfield RL, Mortensen M, Wroblewski K, Littlejohn E, Ehrmann DA.

Hum Reprod. 2011 Nov;26(11):3138-46. doi: 10.1093/humrep/der291. Epub 2011 Sep 9.


State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Geller DH, Pacaud D, Gordon CM, Misra M; of the Drug and Therapeutics Committee of the Pediatric Endocrine Society..

Int J Pediatr Endocrinol. 2011 Aug 26;2011:9. doi: 10.1186/1687-9856-2011-9.


Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.

Nitsche K, Ehrmann DA.

Best Pract Res Clin Endocrinol Metab. 2010 Oct;24(5):717-30. doi: 10.1016/j.beem.2010.08.001. Review.


Initiation of the expression of peroxisome proliferator-activated receptor gamma (PPAR gamma) in the rat ovary and the role of FSH.

Long MJ, Sairam MR, Komar CM.

Reprod Biol Endocrinol. 2009 Dec 7;7:145. doi: 10.1186/1477-7827-7-145.


Polycystic Ovary Syndrome and Obstructive Sleep Apnea.

Tasali E, Van Cauter E, Ehrmann DA.

Sleep Med Clin. 2008 Mar;3(1):37-46.


Risk of cardiovascular events in mothers of women with polycystic ovary syndrome.

Cheang KI, Nestler JE, Futterweit W.

Endocr Pract. 2008 Dec;14(9):1084-94.


Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey.

Cetinkalp S, Karadeniz M, Erdogan M, Zengi A, Cetintas V, Tetik A, Eroglu Z, Kosova B, Ozgen AG, Saygili F, Yilmaz C.

J Assist Reprod Genet. 2009 Jan;26(1):1-6. doi: 10.1007/s10815-008-9280-8. Epub 2008 Dec 5.


Neuroendocrine dysfunction in PCOS: a critique of recent reviews.

Doi SA.

Clin Med Res. 2008 Sep;6(2):47-53. doi: 10.3121/cmr.2008.796. Review. No abstract available.


Menstrual health and the metabolic syndrome in adolescents.

Tfayli H, Arslanian S.

Ann N Y Acad Sci. 2008;1135:85-94. doi: 10.1196/annals.1429.024. Review.


PPAR Gamma: Coordinating Metabolic and Immune Contributions to Female Fertility.

Minge CE, Robker RL, Norman RJ.

PPAR Res. 2008;2008:243791. doi: 10.1155/2008/243791.


Cardiometabolic aspects of polycystic ovarian syndrome.

Cho LW, Randeva HS, Atkin SL.

Vasc Health Risk Manag. 2007;3(1):55-63. Review.

Supplemental Content

Support Center